Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
fda
4
×
biotech
boston blog main
boston top stories
life sciences
national blog main
national top stories
new york blog main
roche
san francisco blog main
tc
23andme
advaxis
aimmune therapeutics
alder biopharmaceuticals
alexander hardy
andrew oxtoby
babies
boston
boulder/denver blog main
boulder/denver top stories
breakup
bridge bio pharma
cancer
cancer immunotherapy
center for medicare and medicaid services
ceo
clinical hold
clinical study
column
combination
commissioner
companion diagnostic
congress
crispr
crispr-cas9
daniel o'day
deals
delisting
democrats
What
big
4
×
medicine
4
×
billion
health
read
acquire
agreed
andme
annual
app
approval
asked
automatically
better
bio
bosley's
bosley’s
break
bridge
broad
bucks
built
cancer
cas
cellphones
ceo
cloud
collides
come
confidence
connect
crime
crispr
culture
dash
data
departure
detects
didn’t
digital
Language
Current search:
medicine
×
big
×
fda
×
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More
@xconomy.com
5 years ago
In a Genentech Redux, Roche Pays $2.4B for Rest of Foundation Medicine
@techcrunch.com
8 years ago
The growing pains of mobile health
@techcrunch.com
9 years ago
We Asked Rock Health Founder Halle Tecco About The Future Of Digital Medicine